Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Simran Sethi

General Practice Lodi, CA Medical Doctor

NPI 1083801484 CMS profile 821055

1901 W Kettleman Ln, Suite 200, Lodi, CA 95242

Open in the dashboard

General payments

$5,762

119 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Simran Sethi of Lodi, CA is reported in the CMS Open Payments database as having received $5,762 across 119 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of General Practice profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,096 33
2024 General $516 27
2023 General $638 24
2022 General $880 30
2021 General $2,567 1
2020 General $65 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Simran Sethi
  • General Practice median
  • Middle half of General Practice
  • National median

In program year 2025, general payments to Simran Sethi were reported at $1,096. Among 4,774 General Practice profiles paid that year, the median was $106 and the middle half received between $35 and $292.

Show as a table
Year Simran Sethi General Practice median Middle half National median
2019 $0 $107 $37–$285 $163
2020 $65 $75 $25–$213 $114
2021 $2,567 $93 $30–$272 $132
2022 $880 $103 $36–$279 $149
2023 $638 $106 $34–$276 $160
2024 $516 $114 $39–$290 $164
2025 $1,096 $106 $35–$292 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Cynosure, LLC $2,567 1 payment
  2. AbbVie, Inc. $1,494 75 payments
  3. Allergan Inc. $363 25 payments
  4. Merz North America, Inc. $313 5 payments
  5. Accord Healthcare, Inc. $280 3 payments
  6. Bioprotect Medical, Inc. $254 1 payment
  7. Palette Life Sciences, Inc. $160 1 payment
  8. Olympus America Inc. $119 2 payments
  9. Sumitomo Pharma America, Inc. $108 1 payment
  10. TissueTech, Inc. $23 1 payment
  11. Other $80 4 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Food and Beverage $3,128 116 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,633 3 payments
Products named General payments · program years 2020–2025
  1. Radio Frequency $2,567 1 payment
  2. BOTOX $819 49 payments
  3. BIOPROTECT BALLOON IMPLANT SYSTEM $254 1 payment
  4. SOLESTA $160 1 payment
  5. CAMCEVI Oncology $160 1 payment
  6. Camcevi Urology Oncology – GnRH agonist for treating adults with advanced prostate cancer $120 2 payments
  7. iTIND System $119 2 payments
  8. ORGOVYX $108 1 payment
  9. NEOX $23 1 payment
  10. CLARIX $23 1 payment
  11. Other $139 8 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

119 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other General Practice in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record